undamentalytics Newsletter
Sign in

Verastem, Inc. balance sheet

At the end of fiscal 2025, Verastem, Inc. had total assets of $246m, total liabilities of $189m and shareholders' equity of $57.2m. It held $205m in cash against $76.3m of debt: net cash of $129m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222024Dec 20242025Dec 2025LTMJun 2026
Cash and equivalents1304468217589205136
Inventory03————22
Total current assets253851451069395223176
Total assets27714515410995102246207
Accounts payable101022541218
Total current liabilities3730171922317278
Long-term debt25351902541——
Total debt956919025417674
Total liabilities153138392148130189157
Shareholders' equity12471158847−295750
Net debt (negative = net cash)−3525−49−21−50−48−129−62
Shares outstanding————33m—78m90m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: BCYC vs VSTMFDMT vs VSTMPLX vs VSTM

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Verastem, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Verastem, Inc.